Light-chain amyloidosis: SCT, novel agents and beyond | Bone Marrow Transplantation
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Monoclonal Gammopathy of Undetermined Significance (MGUS), Asymptomatic Multiple Myeloma, and Amyloidosis
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? - ScienceDirect
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Frontiers | From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis
IJMS | Free Full-Text | Noninvasive Diagnostics of Renal Amyloidosis: Current State and Perspectives
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Mass spectra and m/z values for FLC in patients with AL amyloidosis.... | Download Scientific Diagram
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Biochemical and genetic evaluation in amyloidosis - ppt video online download
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis | Blood Cancer Journal
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Full article: Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Immunoglobulin-Related Amyloidosis: Practice Essentials, Pathophysiology, Etiology
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD